Мышечно-скелетные симптомы при системной красной колчанке с ювенильным дебютом
https://doi.org/10.14412/1996-7012-2023-4-90-96
Аннотация
При ювенильном дебюте системной красной волчанки (СКВ) поражение опорно-двигательного аппарата является одним из наиболее частых проявлений. Мышечно-скелетные симптомы могут быть обусловлены активностью самого заболевания, повреждением, сформировавшимся вследствие активности СКВ, медикаментозным воздействием, а также сопутствующим заболеванием. Не являясь жизнеугрожающими, они, тем не менее, существенно влияют на тяжесть инвалидизации и социальной дезадаптации. В статье рассматривается клиническая характеристика различных причин мышечно-скелетных проявлений при СКВ с дебютом в детском и подростковом возрасте, грамотная интерпретация которых важна для диагностики и оценки активности СКВ, а также для коррекции терапии заболевания, что может способствовать улучшению отдаленного прогноза и качества жизни пациентов.
Ключевые слова
При поддержке: Статья подготовлена в рамках фундаментальной научной темы № 1021051302580-4.
Об авторах
М. И. Каледа
ФГБНУ «Научно-исследовательский институт ревматологии им. В.А. Насоновой»
Россия
Россия
Каледа Мария Игоревна.
115522, Москва, Каширское шоссе, 34А
А. Н. Арефьева
ФГБНУ «Научно-исследовательский институт ревматологии им. В.А. Насоновой»
Россия
Россия
115522, Москва, Каширское шоссе, 34А
И. П. Никишина
ФГБНУ «Научно-исследовательский институт ревматологии им. В.А. Насоновой»
Россия
Россия
115522, Москва, Каширское шоссе, 34А
Литература
1. Groot N, Shaikhani D, Teng YKO, et al. Long-Term Clinical Outcomes in a Cohort of Adults With Childhood-Onset Systemic Lu-pus Erythematosus. Arthritis Rheumatol. 2019 Feb;71(2):290-301. doi: 10.1002/art.40697.
2. Alexander T, Hedrich CM. Systemic lupus erythematosus — Are children miniature adults? Clin Immunol. 2022 Jan;234:108907. doi: 10.1016/j.clim.2021.108907.
3. Асеева ЕА, Лила АМ, Соловьев СК и др. Клинико-иммунологические фенотипы системной красной волчанки, выделенные на основании кластерного анализа данных 400 пациентов ФГБНУ «Научно-исследовательский институт ревматологии им. В.А. Насоновой». Современная ревматология. 2022;16(5):13-21. doi: 10.14412/1996-7012-2022-5-13-21.
4. Levy DM, Kamphuis S. Systemic Lupus Erythematosus in Children and Adolescents. Pediatr Clin North Am. 2012 Apr;59(2):345-64. doi: 10.1016/j.pcl.2012.03.007.
5. Gamal SM, Fouad N, Yosry N, et al. Disease characteristics in patients with juvenile- and adult-onset systemic lupus erythematosus: A multi-center comparative study. Arch Rheumatol. 2021 Dec 24;37(2):280-287. doi: 10.46497/ArchRheumatol.2022.8888.
6. Massias JS, Smith EM, Al-Abadi E, et al. Clinical and laboratory phenotypes in juveni-le-onset Systemic Lupus Erythematosus ac-ross ethnicities in the UK. Lupus. 2021 Apr; 30(4):597-607. doi: 10.1177/0961203320984251.
7. Massias JS, Smith EMD, Al-Abadi E, et al. Clinical and laboratory characteristics in juvenile-onset systemic lupus erythematosus across age groups. Lupus. 2020 Apr;29(5): 474-481. doi: 10.1177/0961203320909156.
8. Novak GV, Marques M, Balbi V, et al. Anti-RO/SSA and anti-La/SSB antibodies: Association with mild lupus manifestations in 645 childhood-onset systemic lupus erythematosus. Autoimmun Rev. 2017 Feb;16(2): 132-135. doi: 10.1016/j.autrev.2016.12.004.
9. Ceccarelli F, Perricone C, Cipriano E, et al. Joint involvement in systemic lupus erythematosus: From pathogenesis to clinical assessment. Semin Arthritis Rheum. 2017 Aug;47(1): 53-64. doi: 10.1016/j.semarthrit.2017.03.022.
10. Dorner T, Vital EM, Ohrndorf S, et al. A Narrative Literature Review Comparing the Key Features of Musculoskeletal Involvement in Rheumatoid Arthritis and Systemic Lupus Erythematosus. Rheumatol Ther. 2022 Jun; 9(3):781-802. doi: 10.1007/s40744-022-00442-z.
11. Hochberg MC. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum. 1997 Sep;40(9):1725. doi: 10.1002/art.1780400928.
12. Petri M, Orbai AM, Alarcon GS, et al. Derivation and validation of the Systemic Lupus International Collaborating Clinics classification criteria for systemic lupus erythematosus. Arthritis Rheum. 2012 Aug;64(8): 2677-86. doi: 10.1002/art.34473.
13. Aringer M, Costenbader K, Daikh D, et al. 2019 European League Against Rheumatism/American College of Rheumatology Classification Criteria for Systemic Lupus Erythematosus. Arthritis Rheumatol. 2019 Sep;71(9):1400-1412. doi: 10.1002/art.40930.
14. Batu ED, Akca UK, Kisaarslan AP, et al. The Performances of the ACR 1997, SLICC 2012, and EULAR/ACR 2019 Classification Criteria in Pediatric Systemic Lupus Erythematosus. J Rheumatol. 2021 Jun;48(6): 907-914. doi: 10.3899/jrheum.200871.
15. Chang LS, Huang PY, Kuo HC, et al. Diagnostic accuracy of the American College of Rheumatology-1997, the Systemic Lupus International Collaborating Clinics-2012, and the European League Against Rheumatism-2019 criteria for juvenile systemic lupus erythematosus: A systematic review and network meta-analysis. Autoimmun Rev. 2022 Sep; 21(9):103144. doi: 10.1016/j.autrev.2022.103144.
16. Nelson MC, Chandrakasan S, Ponder L, et al. Clinical Determinants of Childhood Onset Systemic Lupus Erythematosus among Early and Peri-Adolescent Age Groups. Children (Basel). 2022 Nov 30;9(12):1865. doi: 10.3390/children9121865.
17. Lewandowski LB, Schanberg LE, Thielman N, et al. Severe disease presentation and poor outcomes among pediatric systemic lupus erythematosus patients in South Africa. Lupus. 2017 Feb;26(2):186-194. doi: 10.1177/0961203316660625.
18. Wen L, Chen Z, Jin Z, et al. Clinical and laboratorial outcome of different age-onset systemic lupus erythematosus patients in Jiangsu, China: a multicentre retrospective study. Sci Rep. 2022 Jun 23;12(1):10683. doi: 10.1038/s41598-022-14840-4.
19. Каледа МИ, Никишина ИП, Салугина СО, Родионовская СР. Особенности дебюта системной красной волчанки в детском возрасте по данным ретроспективного исследования. Педиатрия. Журнал им. Г.Н. Сперанского. 2019;98(3):99-104.
20. Ceccarelli F, Natalucci F, Olivieri G, et al. Erosive arthritis in systemic lupus erythematosus: not only Rhupus. Lupus. 2021 Nov;30(13): 2029-2041. doi: 10.1177/09612033211051637.
21. Tani C, Carli L, Stagnaro C, et al. Imaging of joints in systemic lupus erythematosus. Clin Exp Rheumatol. 2018 Sep-Oct;36 Suppl 114(5):68-73. Epub 2018 Oct 1.
22. Ogura T, Hirata A, Hayashi N, et al. Comparison of ultrasonographic joint and tendon findings in hands between early, treatment-naive patients with systemic lupus erythematosus and rheumatoid arthritis. Lupus. 2017 Jun;26(7):707-714. doi: 10.1177/0961203316676375.
23. Ambrose N, Morgan TA, Galloway J, et al; UK JSLE Study Group. Differences in disease phenotype and severity in SLE across age groups. Lupus. 2016 Dec;25(14): 1542-1550. doi: 10.1177/0961203316644333.
24. Sakamoto AP, Silva CA, Ferriani MP, et al. Characterization of chronic arthritis in a multicenter study of 852 childhood-onset systemic lupus erythematosus patients. Rheumatol Int. 2016 Dec;36(12):1641-1648. doi: 10.1007/s00296-016-3564-6.
25. Gormezano NW, Silva CA, Aikawa NE, et al. Chronic arthritis in systemic lupus erythematosus: distinct features in 336 paediatric and 1830 adult patients. Clin Rheumatol. 2016 Jan;35(1):227-31. doi: 10.1007/s10067-015-3127-3.
26. Жорняк АП, Иванова ММ. Деформирующая артропатия кистей (синдром Жакку) при системной красной волчанке. Научно-практическая ревматология. 2005;(4):42-46.
27. Martini A, Ravelli A, Viola S, Burgio RG. Systemic lupus erythematosus with Jaccoud's arthropathy mimicking juvenile rheumatoid arthritis. Arthritis Rheum. 1987 Sep;30(9): 1062-4. doi: 10.1002/art.1780300915.
28. Toone EC, Irby R, Pierce EL. The L.E. cell in rheumatoid arthritis. Am J Med Sci. 1960 Nov;240:599-608.
29. Schur PH. Systemic lupus erythematosus. In: Beeson PB, McDermott W, editors. Cecil-Loeb Texbook of Medicine. Philadelphia: Sanders; 1971. P. 821.
30. Li J, Wu H, Huang X, et al. Clinical ana-lysis of 56 patients with rhupus syndrome. Medicine (Baltimore). 2014 Aug;93(10):e49. doi: 10.1097/MD.0000000000000049.
31. Ziaee V, Moradinejad MH, Bayat R. RHUPUS Syndrome in Children: A Case Series and Literature Review. Case Rep Rheumatol. 2013;2013:819629. doi: 10.1155/2013/819629.
32. Tiniakou E, Goldman D, Corse A, et al. Clinical and histopathological features of myositis in systemic lupus erythematosus. Lupus Sci Med. 2022 Mar;9(1):e000635. doi: 10.1136/lupus-2021-000635/
33. Bitencourt N, Solow EB, Wright T, Bermas BL. Inflammatory myositis in systemic lupus erythematosus. Lupus. 2020 Jun;29(7): 776-781. doi: 10.1177/0961203320918021.
34. Font J, Cervera R, Ramos-Casals M, et al. Clusters of clinical and immunologic features in systemic lupus erythematosus: analysis of 600 patients from a single center. Semin Arthritis Rheum. 2004 Feb;33(4):217-30. doi: 10.1053/s0049-0172(03)00133-1.
35. Record JL, Beukelman T, Cron RQ. High prevalence of myositis in a southeastern United States pediatric systemic lupus erythematosus cohort. Pediatr Rheumatol Online J. 2011 Aug 9;9:20. doi: 10.1186/1546-0096-9-20.
36. Maazoun F, Frikha F, Snoussi M, et al. Systemic lupus erythematosusmyositis overlap syndrome: report of 6 cases. Clin Pract. 2011 Nov 2;1(4):e89. doi: 10.4081/cp.2011.e89.
37. Mondal R, Sarkar S, Nandi M, et al. Overlap syndrome: a child cohort. Indian J Pediatr. 2013 May;80(5):434-5. doi: 10.1007/s12098-012-0825-6.
38. Shah S, Chengappa K, Negi V. Systemic lupus erythematosus and overlap: A clinician perspective. Clinical Dermatology Review. 2019; 3(1):12-17. doi: 10.4103/CDR.CDR_44_18.
39. Lin KH, Kao JK. Overlap syndrome in a 12-year-old girl with systemic lupus erythematosus and anti-jo antibody-positive polymyositis: a case report. Pediatr Rheumatol Online J. 2022 Oct 21;20(1):92. doi: 10.1186/s12969-022-00753-z.
40. Silver EM, Ochoa W. Glucocorticoid-Induced Myopathy in a Patient with Systemic Lupus Erythematosus (SLE): A Case Report and Review of the Literature. Am J Case Rep. 2018 Mar 11;19:277-283. doi: 10.12659/ajcr.906377.
41. Florica B, Aghdassi E, Su J, et al. Peripheral neuropathy in patients with systemic lupus erythematosus. Semin Arthritis Rheum. 2011 Oct;41(2):203-11. doi: 10.1016/j.semarthrit.2011.04.001.
42. Muscal E, Brey RL. Neurologic manifestations of systemic lupus erythematosus in children and adults. Neurol Clin. 2010 Feb; 28(1):61-73. doi: 10.1016/j.ncl.2009.09.004.
43. Almeida RT, de Arruda Campos LM, Ai-kawa NE, et al. Peripheral polineuropathy in patients with juvenile systemic lupus erythematosus. Bras J Rheumatol. 2009;49:362-374.
44. Giani T, Smith EM, Al-Abadi E, et al; UK JSLE Cohort Study. Neuropsychiatric involvement in juvenile-onset systemic lupus erythematosus: Data from the UK Juvenile-onset systemic lupus erythematosus cohort study. Lupus. 2021 Oct;30(12):1955-1965. doi: 10.1177/09612033211045050.
45. Hanly JG, Li Q, Su L, et al. Peripheral Nervous System Disease in Systemic Lupus Erythematosus: Results From an International Inception Cohort Study. Arthritis Rheumatol. 2020 Jan;72(1):67-77. doi: 10.1002/art.41070.
46. Rella V, Rotondo C, Altomare A, et al. Bone Involvement in Systemic Lupus Erythematosus. Int J Mol Sci. 2022 May 22;23(10): 5804. doi: 10.3390/ijms23105804.
47. Zhu GQ, Qiu HX, Ma XM, Liu MX. Cli-nical Study on Systemic Lupus Erythematosus Complicated with Knee Bone Infarction. Int J Clin Pract. 2022 Jul 18;2022:7025811. doi: 10.1155/2022/7025811.
48. Zhang Y, Duan XM, Mei HB. Imaging findings of bone infarction in children with systemic lupus erythematosus. Zhongguo Gu Shang. 2018 Mar 25;31(3):272-275. doi: 10.3969/j.issn.1003-0034.2018.03.016.
49. Holland MJ, Beresford MW, Feldman BM, et al; PRINTO and PRCSG Investigators. Measuring Disease Damage and Its Severity in Childhood-Onset Systemic Lupus Erythematosus. Arthritis Care Res (Hoboken). 2018 Nov;70(11):1621-1629. doi: 10.1002/acr.23531.
50. Yang Y, Kumar S, Lim LS, et al. Risk Factors for Symptomatic Avascular Necrosis in Childhood-onset Systemic Lupus Erythematosus. J Rheumatol. 2015 Dec;42(12):2304-9. doi: 10.3899/jrheum.150464.
51. Gurion R, Tangpricha V, Yow E, et al; Atherosclerosis Prevention in Pediatric Lupus Erythematosus Investigators. Avascular necrosis in pediatric systemic lupus erythematosus: a brief report and review of the literature. Pediatr Rheumatol Online J. 2015 Apr 23;13:13. doi: 10.1186/s12969-015-0008-x.
52. Jin W, Yang X, Lu M. Juvenile-onset multifocal osteonecrosis in systemic lupus erythematosus: A case report. Medicine (Baltimore). 2021 Jan 15;100(2):e24031. doi: 10.1097/MD.0000000000024031.
53. Dubois EL, Cozen L. Avascular (aseptic) bone necrosis associated with systemic lupus erythematosus. JAMA. 1960 Oct 22;174:966-71. doi: 10.1001/jama.1960.03030080028005.
54. Brunner HI, Silverman ED, To T, et al. Risk factors for damage in childhood-onset systemic lupus erythematosus: cumulative disease activity and medication use predict disease damage. Arthritis Rheum. 2002 Feb; 46(2):436-44. doi: 10.1002/art.10072.
55. Ravelli A, Duarte-Salazar C, Buratti S, et al. Assessment of damage in juvenile-onset systemic lupus erythematosus: a multicenter cohort study. Arthritis Rheum. 2003 Aug 15; 49(4):501-7. doi: 10.1002/art.
56. Yang Y, Calvo-Alen J, McGwin G, et al. Systemic lupus erythematosus in a multiethnic US cohort (LUMINA): XXIV. Cytotoxic treatment is an additional risk factor for the development of symptomatic osteonecrosis in lupus patients: results of a nested matched case-control study. Ann Rheum Dis. 2006 Jun; 65(6):785-90. doi: 10.1136/ard.2005.040428. Epub 2005 Nov 3.
57. Tsai HL, Chang JW, Lu JH, Liu CS. Epidemiology and risk factors for avascular ne-crosis in childhood systemic lupus erythematosus in a Taiwanese population. Sci Rep. 2020 Sep 23;10(1):15563. doi: 10.1038/s41598-020-71923-w.
58. Mok CC, Lau CS, Wong RW. Risk factors for avascular bone necrosis in systemic lupus erythematosus. Br J Rheumatol. 1998 Aug; 37(8):895-900. doi: 10.1093/rheumatology/37.8.895.
59. Compeyrot-Lacassagne S, Tyrrell PN, Atenafu E, et al. Prevalence and etiology of low bone mineral density in juvenile systemic lupus erythematosus. Arthritis Rheum. 2007 Jun;56(6):1966-73. doi: 10.1002/art.22691.
60. Hao S, Zhang J, Huang B, et al. Bone re-modeling serum markers in children with systemic lupus erythematosus. Pediatr Rheumatol Online J. 2022 Jul 27;20(1):54. doi: 10.1186/s12969-022-00717-3.
61. LeBlanc CM, Ma J, Taljaard M, et al; Canadian STeroid-Associated Osteoporosis in Pediatric Population (STOPP) Consortium. Incident Vertebral Fractures and Risk Factors in the First Three Years Following Glucocorticoid Initiation Among Pediatric Patients With Rheumatic Disorders. J Bone Miner Res. 2015 Sep;30(9):1667-75. doi: 10.1002/jbmr.2511.
62. Wolfe F, Clauw DJ, Fitzcharles MA, et al. Fibromyalgia criteria and severity scales for clinical and epidemiological studies: a modification of the ACR Preliminary Diagnostic Criteria for Fibromyalgia. J Rheumatol. 2011 Jun;38(6):1113-22. doi: 10.3899/jrheum.100594.
63. Kotter I, Neuscheler D, Gunaydin I, et al. Is there a predisposition for the development of autoimmune diseases in patients with fibromyalgia? Retrospective analysis with long term follow-up. Rheumatol Int. 2007 Sep;27(11): 1031-9. doi: 10.1007/s00296-007-0413-7.
64. Ting TV, Barnett K, Lynch-Jordan A, et al. 2010 American College of Rheumatology Adult Fibromyalgia Criteria for Use in an Adolescent Female Population with Juvenile Fibromyalgia. J Pediatr. 2016 Feb;169: 181-7.e1. doi: 10.1016/j.jpeds.2015.10.011.
65. Buskila D, Press J, Abu-Shakra M. Fibromyalgia in systemic lupus erythematosus: prevalence and clinical implications. Clin Rev Allergy Immunol. 2003 Aug;25(1):25-8. doi: 10.1385/CRIAI:25:1:25.
66. Torrente-Segarra V, Salman-Monte TC, Rua-Figueroa Н, et al; RELESSER Study Group of the Spanish Society of Rheumatology (SER); Study Group of Systemic Autoimmune Diseases of the SER (EAS-SER). Fibromyalgia prevalence and related factors in a large registry of patients with systemic lupus erythematosus. Clin Exp Rheumatol. 2016 Mar-Apr;34(2 Suppl 96):S40-7. Epub 2015 Nov 17
67. Elefante E, Tani C, Stagnaro C, et al. Articular involvement, steroid treatment and fibromyalgia are the main determinants of patient-physician discordance in systemic lupus erythematosus. Arthritis Res Ther. 2020 Oct 14; 22(1):241. doi: 10.1186/s13075-020-02334-5.
68. Jones JT, Cunningham N, Kashikar-Zuck S, Brunner HI. Pain, Fatigue, and Psyhological Impact on Health-Related Quality of Life in Childhood-Onset Lupus. Arthritis Care Res (Hoboken). 2016 Jan;68(1):73-80. doi: 10.1002/acr.22650.
69. Donnelly C, Cunningham N, Jones JT, et al. Fatigue and depression predict reduced health-related quality of life in childhood-on-set lupus. Lupus. 2018 Jan;27(1):124-133. doi: 10.1177/0961203317716317.
70. Bao S, Lu J, Huang H, et al. Major Infections of Newly Diagnosed Childhood-Onset Systemic Lupus Erythematosus. J Multidiscip Healthc. 2023 May 24;16:1455-1462. doi: 10.2147/JMDH.S408596.
71. Huang YF, Chang YS, Chen WS, et al. Incidence and risk factors of osteomyelitis in adult and pediatric systemic lupus erythema-tosus: a nationwide, population-based cohort study. Lupus. 2019 Jan;28(1):19-26. doi: 10.1177/0961203318811601.
72. Blay G, Ferriani MP, Buscatti IM, et al. Pyomyositis in childhood-systemic lupus erythematosus. Rev Bras Reumatol Engl Ed. 2016 Jan-Feb;56(1):79-81. English, Portuguese. doi: 10.1016/j.rbre.2014.04.005.
Рецензия
Для цитирования:
Каледа МИ, Арефьева АН, Никишина ИП. Мышечно-скелетные симптомы при системной красной колчанке с ювенильным дебютом. Современная ревматология. 2023;17(4):90-96. https://doi.org/10.14412/1996-7012-2023-4-90-96
For citation:
Kaleda MI, Arefieva AN, Nikishina IP. Musculoskeletal symptoms in juvenile onset systemic lupus erythematosus. Sovremennaya Revmatologiya=Modern Rheumatology Journal. 2023;17(4):90-96. (In Russ.) https://doi.org/10.14412/1996-7012-2023-4-90-96
Просмотров:
524
Послать статью по эл. почте 